Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 3
2011 2
2012 3
2013 4
2014 4
2015 5
2016 3
2017 8
2018 10
2019 2
2020 4
2021 4
2022 3
2023 8
2024 11
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
The cross-regulation between SOX15 and Wnt signaling pathway.
Moradi A, Ghasemi F, Anvari K, Hassanian SM, Simab SA, Ebrahimi S, Hesari A, Forghanifard MM, Boroushaki MT, ShahidSales S, Avan A. Moradi A, et al. Among authors: anvari k. J Cell Physiol. 2017 Dec;232(12):3221-3225. doi: 10.1002/jcp.25802. Epub 2017 Mar 27. J Cell Physiol. 2017. PMID: 28092101 Review.
Retraction notice to "Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma" [Life Sci. 328 (2023) 121865].
Khalili-Tanha G, Fiuji H, Gharib M, Moghbeli M, Khalili-Tanha N, Rahmani F, Shakour N, Maftooh M, Hassaniana SM, Asgharzadeh F, Shahidsales S, Anvari K, Mozafari MR, Ferns GA, Batra J, Giovannetti E, Khazaei M, Avan A. Khalili-Tanha G, et al. Among authors: anvari k. Life Sci. 2024 Dec 1;358:123106. doi: 10.1016/j.lfs.2024.123106. Epub 2024 Oct 16. Life Sci. 2024. PMID: 39419712 No abstract available.
The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.
Keyvani V, Mollazadeh S, Riahi E, Mahmoudian RA, Tabari M, Lagzian E, Ghorbani E, Akbarzade H, Gholami AS, Gataa IS, Hassanian SM, Ferns GA, Khazaei M, Avan A, Anvari K. Keyvani V, et al. Among authors: anvari k. Curr Pharm Des. 2024;30(13):975-987. doi: 10.2174/0113816128291955240306112558. Curr Pharm Des. 2024. PMID: 38500284 Review.
Insight into RNA-based Therapies for Ovarian Cancer.
Keyvani V, Mahmoudian RA, Mollazadeh S, Kheradmand N, Ghorbani E, Khazaei M, Saeed Al-Hayawi I, Hassanian SM, Ferns GA, Avan A, Anvari K. Keyvani V, et al. Among authors: anvari k. Curr Pharm Des. 2023;29(34):2692-2701. doi: 10.2174/0113816128270476231023052228. Curr Pharm Des. 2023. PMID: 37916491
Recent Progress in the Application of Exosome Analysis in Ovarian Cancer Management.
Keyvani V, Ghale-Noie ZN, Mollazadeh S, Mahmoudian RA, Ghorbani E, Naderi H, Khazaei M, Hassanian SM, Ferns GA, Avan A, Anvari K. Keyvani V, et al. Among authors: anvari k. Curr Cancer Drug Targets. 2024;24(9):920-929. doi: 10.2174/0115680096281906231213055422. Curr Cancer Drug Targets. 2024. PMID: 38284712 Review.
71 results